Biomerica logo
Biomerica
BMRA | NASDAQ
Chart Builder DCF Calculator
$1.32
-$0.04 (-2.94%)
At close: Nov 16, 2026, 4:00 PM ET
$1.32
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Biomerica Company Profile

Company profile explained

Company Profile

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste. Biomerica primarily sells its products for gastrointestinal disorders, food sensitivities, diabetes, and a variety of specialized diagnostic evaluations. Its distribution channels include physicians' clinics, retail pharmacies, and hospital/clinical laboratories. The company is currently developing InFoods, a diagnostic-guided therapy technology for irritable bowel syndrome; products for Helicobacter pylori; and comprehensive diagnostic tools for COVID-19, encompassing their development, testing, validation, and sale. Established in 1971, Biomerica, Inc. maintains its corporate headquarters in Irvine, California.

Key Executives

Name Position
Zackary S. Irani Chief Executive Officer & Director
Allen C. Barbieri Executive Vice-Chairman of the Board & Corporate Secretary
Gary Lu Principal Accounting Officer
Lucy Liu Director of Manufacturing & Technical Operations
Scott Madel Chief Commercial Officer
Xiaoxuan Qu Principal Financial Officer & Principal Accounting Officer

Latest SEC Filings

Date Type Title
Oct 16, 2026 DEF 14A Filing
Oct 15, 2026 10-Q Quarterly Report
Oct 15, 2026 8-K Current Report
Oct 07, 2026 EFFECT Filing
Oct 07, 2026 EFFECT Filing
Sep 28, 2026 10-K/A [Amend] Annual Report
Sep 24, 2026 S-3 Filing
Sep 24, 2026 S-3 Filing
Sep 10, 2026 3 Filing
Sep 08, 2026 3 Filing
View All SEC Filings ➞
Biomerica
Biomerica logo
Country United States
IPO Date Sep 7, 1984
Industry Medical - Devices
Sector Healthcare
Employees 50
CEO Zackary S. Irani

Contact Details

17571 Von Karman Avenue Irvine, California 92614 United States

Stock Details

Ticker Symbol BMRA
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0000073290
CUSIP Number 09061H406
ISIN Number US09061H4065
SIC Code 2835

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.